Taking into account the limitations of experimental studies, we believe that our findings will encourage consideration of this novel therapeutic approach for patients with SLE associated with PAH, in which Cat S may be markedly upregulated, as suggested by recent findings in SLE patients. Here, CAT is linked to pulmonary arterial hypertension.